Conquering Diseases

Study Of An Investigational Drug For Maintenance Therapy Following Remission Of Acute Myeloid Leukemia


Seeking men and women whose acute myeloid leukemia is in remission following an initial treatment with conventional chemotherapy for a study of an investigational drug for maintenance therapy


Participants in this study will be randomly assigned to receive either the investigational drug or the best available standard treatment.

What we're hoping for

We are studying whether an investigational drug is safe and effective compared to the standard maintenance therapy for people whose acute myeloid leukemia has gone into remission following their initial treatment with conventional chemotherapy.

Additional Information Identifier: NCT04102020

 Principal Investigator

Jan  Cerny, MD, PhD

UMass Memorial Health

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655